MDGL icon

Madrigal Pharmaceuticals

111 hedge funds and large institutions have $831M invested in Madrigal Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 47 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

24% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 17

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

51% less call options, than puts

Call options by funds: $6.99M | Put options by funds: $14.2M

Holders
111
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.99M
Puts
$14.2M
Net Calls
Net Calls Change

Top Buyers

1 +$65.5M
2 +$3.37M
3 +$2.25M
4
SG Americas Securities
SG Americas Securities
New York
+$2.05M
5
Morgan Stanley
Morgan Stanley
New York
+$1.77M

Top Sellers

1 -$25.9M
2 -$9.96M
3 -$7.62M
4
Invesco
Invesco
Georgia
-$7.01M
5
Citadel Advisors
Citadel Advisors
Florida
-$4.01M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$319K
77
$318K
78
$318K
79
$317K
80
$255K
81
$252K
82
$247K
83
$230K
84
$224K
85
$221K
86
$211K
87
$200K
88
$175K
89
$147K
90
$144K
91
$134K
92
$127K
93
$120K
94
$116K
95
$111K
96
$106K
97
$64K
98
$63K
99
$52K
100
$43K